Learn / Clinical Research Management / Close-out, transparency and professional practice
Trial and site close-out
12 minute read · 6-question quiz
What you will learn
List the steps of site close-out and trial close-out
Explain final reconciliation and archiving responsibilities
Describe what happens to participants, samples and data after the trial
A trial is not finished when the last participant has their last visit. Close-out ensures that everything is complete, documented and ready for analysis, reporting and inspection.
Site close-out
The close-out visit (COV) happens after the last participant visit and database cleaning at the site. The CRA checks and confirms that:
- All CRFs are complete and queries resolved.
- All SAEs have been reported and followed up.
- Investigational product is reconciled, and unused product returned or destroyed with documentation.
- The Investigator Site File is complete and consistent with the TMF.
- Biological samples are shipped, stored or destroyed as per protocol and consent.
- Equipment loaned by the sponsor is returned, and supplies reconciled.
- Participants' continued care is arranged, including access to the product if the protocol or ethics plan provides it.
- Final reports to ethics committee and regulator are planned or submitted.
- Archiving arrangements for the ISF and source documents are agreed, with the retention period and contact for access.
- Financial reconciliation of payments to the site is complete.
Trial close-out (sponsor or CRO)
- Database lock, unblinding and analysis.
- All sites closed.
- TMF reviewed for completeness and quality.
- Final safety reconciliation.
- Clinical study report and results registered and published.
- Notification to regulators and ethics committees that the trial has ended.
- Archiving of the TMF and databases.
After the trial: obligations to participants and communities
- Thank participants and tell them how the trial ended.
- Share results in plain language, with communities and with those who took part, as agreed in the protocol or consent.
- Continued access to an effective treatment for participants, where appropriate and agreed with the ethics committee.
- Return of research results that matter to participants' health, according to the consent form.
- Sample use: retain or destroy stored samples exactly as consent allows. New uses need new approval.
Retention and access
The sponsor tells sites in writing when they may destroy records. Sites keep records secure, readable and accessible for inspection, and notify the sponsor if the institution changes, the PI leaves or storage is moved.
Summary
Close-out verifies complete CRFs, queries, SAEs, product, samples, site file, final reports and archiving.
Trial close-out includes database lock, analysis, CSR, TMF review and notifications.
Obligations continue to participants and communities after the trial ends.
Records must be kept for the required period, accessible and secure.
Check your understanding
Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.